CHANGES IN FIBRINOGENEMIA, FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS AND EUGLOBULIN LYSIS TIME DURING POSTOPERATIVE PERIOD

被引:0
|
作者
LASIERRA, J
LOZANO, R
NAVARRO, M
PERERA, C
VILADES, E
机构
[1] FAC MED SARAGOSSA, DEPT SURG, Zaragoza, SPAIN
[2] FAC MED SARAGOSSA, SERV HAEMOSTASIS & THROMBOSIS, Zaragoza, SPAIN
来源
ISRAEL JOURNAL OF MEDICAL SCIENCES | 1973年 / 9卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:960 / 960
页数:1
相关论文
共 50 条
  • [31] SOLUBLE UNCLOTTABLE COMPLEXES FORMED IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) DURING FIBRINOGEN-FIBRIN CONVERSION AND THEIR POTENTIAL SIGNIFICANCE IN PATHOLOGY
    LIPINSKI, B
    WEGRZYNO.Z
    BUDZYNSK.AZ
    KOPEC, M
    LATALLO, ZS
    KOWALSKI, E
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1967, 17 (1-2): : 65 - +
  • [32] CHANGES IN THE FIBRINOGEN-FIBRIN DECOMPOSITION PRODUCTS IN NEWBORNS WITH A LOW BIRTH-WEIGHT
    THIEME, G
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1979, 34 (43): : 2150 - 2155
  • [33] FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS IN THE DIAGNOSIS OF PULMONARY-EMBOLISM IN CRITICALLY ILL PATIENTS
    JARENO, AJ
    DELASERNA, JL
    CORRAL, EE
    GALLEGO, J
    PATINO, R
    CRITICAL CARE MEDICINE, 1980, 8 (11) : 646 - 650
  • [34] ASSAYS FOR FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS IN BIOLOGICAL-FLUIDS - SOME METHODOLOGICAL ASPECTS
    DONATI, MB
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03): : 652 - 660
  • [35] DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms
    Ke, Chiao-Hsu
    Lin, Chen-Si
    Sio, Ka-Mei
    Wu, Chun-Hung
    Xia, Yuan-Yuan
    Lee, Jih-Jong
    Hu, Chin-Hao
    Liu, Cheng-Chi
    Liaw, Bor-Song
    Cheng, Chiao-Lei
    Lin, Keng-Hsuan
    Wang, Yu-Shan
    VETERINARY QUARTERLY, 2024, 44 (01) : 1 - 10
  • [36] DETERMINATION OF FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS (FDP) IN ASCITIC FLUID - VALUABLE DIAGNOSTIC TEST
    SVANBERG, L
    ASTEDT, B
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1975, : 44 - 44
  • [37] Aminoterminal conformational changes during fibrinogen-fibrin conversion studied by surface labeling
    HenschenEdman, AH
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1559 - O1559
  • [38] MONOCLONAL-ANTIBODIES TO FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS WHICH CONTAIN D-DOMAIN
    MATSUMOTO, T
    NISHIJIMA, Y
    TERAMURA, Y
    FUJINO, K
    HIBINO, M
    HIRATA, M
    THROMBOSIS RESEARCH, 1985, 38 (03) : 297 - 302
  • [39] STANDARIZATION OF STAPHYLOCOCCAL CLUMPING TEST (SCT) FOR DETECTION OF FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS (FDP) IN SERUM
    CONTRERASC, P
    SALAZARM, R
    REVISTA MEDICA DE CHILE, 1975, 103 (08) : 551 - 554
  • [40] COMPARISON BETWEEN RADIOIMMUNOASSAY AND OTHER IMMUNOLOGICAL TECHNIQUES FOR MEASUREMENT OF FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS IN SERUM
    RATKY, SM
    MARTIN, MJ
    GORDON, YB
    BAKER, LRI
    LESLIE, J
    CHARD, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1975, 30 (02) : 145 - 149